Catalyst Wire Dossier Catalyst Wire Dossier

Sonrotoclax

Drug timelines are a Plus or Pro feature.

24 regulatory and trial events tracked for Sonrotoclax, covering 2024-07-11 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Sonrotoclax, Zanubrutinib and Rituximab in Previously Untreated Patients With Follicular Lymphoma [Phase 2]

See pricing